drugset / Trial / NCT05302531

Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

NCT05302531

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the drug absorption of oral antibiotics in patients with short bowel syndrome.

Timeline

Start
2022-12-09
Primary completion
2024-12
Completion
2025-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified Intravenous
Subject Levofloxacin Small molecule Intravenous
Subject Ofloxacin Small molecule Intravenous
Subject Sulfamethoxazole Small molecule Intravenous
Subject Trimethoprim Small molecule Intravenous